Radioiodine/Retention/Japanese A dose of 2.74 kBq of carrier-free 131I (Nal) was given orally to 2 male adults (A and B) in their routine works under a limitation of iodine intake for A and a fairly free access to iodine intake for B for 2 weeks predose. In both the thyroid and the whole-body, the reten tions were expressed with a 2 term-exponential function. The metabolic data for subjects A and B are as follows: (1) a peak thyroidal uptake; 28.9 and 10.3% at 24 hours postdose (2) an effective half-time in the thyroid; 6.4 and 6.1 days (3) an effective half-time in the thighs; 0.2 and 0.3 day (4) excretion of 1311 in the first 24-hr urine; 72 and 88% of the given dose (5) an amount of stable iodine in 24-hr urine before 1311 administration; 0.29 and 2.0 to 5.4 mg. The dose commitments were estimated 1.19 and 0.39 mGy to the thyroid and 1 and 0.5 jiGy to the total body for subjects A and B, respectively. The same results were ob tained using the "S", by MIRD.
INTRODUCTION
Internal radiation exposure due to radioactive iodines is important in aspect of the population dose of the general public and the radiation workers because of their high fission yields, the frequent use in the field of research and industry, and the latent possibility of environmental release. A metabolic model is required to estimate the internal radiation dose and the dose commitment to population at large due to intake of the radioiodines.
The dietary custom of frequently consuming seafood rich in stable iodine') and the rather small physique of the Japanese would result in some differences in the parameters of metabolic model from those for the reference man developed by the International Commission on Radiological Protection (ICRP) which was based on the data from Caucasian'). Among the parameters, the iodine uptake rate in the thyroid at 24 hours postdose has been obtained usually as part of diagnosis to the thyroidal function using 131I, and the distribution of values for normal Japanese subjects was summarized to find rather low average uptake rate of about 20% of the initial dose, that is, lower by almost 10% than that for the reference mane, 3).
However, it has been reported that radioiodine uptake rate in human thyroid attains the peak later than 24 hours postdose4 ' 5) . This means that the radiation dose is inevitably underestimated by the application of 24-hr value. Furthermore, the uptake rate for radioiodines with longer physical half-times like 1251 and 129I may attain the peak later than 24 hours postdose and may be different from that for 131I.
Information of a biological half-time for thyroidal iodine for the Japanese is more scarce than that of the uptake rate.
A single dose experiment on 2 volunteers of male adult in their routine works was undertaken to obtain the above-mentioned metabolic data.
MATERIAL AND METHOD
A dose of 2.74 kBq (73 nCi) was chosen for an amount given orally to the subject. The internal radiation dose to the thyroid was estimated using the meta bolic parameters measured in the U.S.A. and assuming tentatively a thyroidal uptake rate of 20% of the initial dose. The estimated dose was proved to be lower than 5 mSv (500 mrem), the legal annual dose limit in Japan for general public. In order to obtain an effective half-time of 131I in the thyroid success fully, the subjects were asked to refrain from taking seafood, especially brown algae, having very rich iodine content'), for 2 weeks before the administration of 131 I. However, for subject B, the limitation of stable iodine intake was changed and sometimes normal Japanese food customs including sea products were taken except the last 2 days before 131I administration when he gained freely access to normal Japanese food to obtain rather realistic biological parameters for iodine retention, because of no allowance for another experiment under a usual iodine intake by the Japanese.
The subjects were administered I'll as sodium iodide aquatic solution and were imposed no limitations to their intake of food.
The total body, neck and thighs were measured at intervals till about 3 weeks postdose by using a whole-body counter with 2 NaI (TI) detectors at the National Institute of Radiological Sciences'). The upper detector alone was used to measure 131I in the part of body by fixing the detector above a visual field of 20 cm (body width) x 16 cm which was demarcated with two 5-cm thick lead collimators. In this geometry, the vertical edges of the collimator almost touched the body sur face of the subject in the spinal position, and y-rays from radionuclides in the body outside the visual field could be effectively eliminated from counting systems.
A 30 minute measurement was taken place for each part of the body in question by this geometry. Calibrations for 40K and 1311 were carried out using phantoms in the geometry similar to that for the subject. A phantom for the thyroid was prepared based on the ORINS type neck phantom as follows: 2 small vinyl chloride bottles containing each 511 Bq (13.8 nCi) of 1311 absorbed on 7.4 g of anion exchange resin were fixed symmetrically to the longitudinal body axis at a depth of 3 cm in water filled into a 15 cm-diameter acrylic acid resin cylinder. The contribution of y-rays of 40K in the visual field to a counting rate in an energy range for 131I measurement was estimated based on a ratio of net count rates in the energy range for 1311 to those for 40K obtained in the measurements of 2 whole-body phantoms with and without a known amount of KCl solved in distilled water. To estimate the amount of 1311 existing in the tissues of neck except thyroid, the quantity of 1311 in the thighs was used. The count rates of 1311 in the thighs and those in a reference source for excreta were com pared to estimate the burden in the segment. The amount of 131I in the thighs was subtracted from that in the neck. The thyroidal burden was then obtained by dividing the remainder by the counting efficiency for the thyroid phantom.
1311 whole-body retention was also followed up by a linear scanning method with a velocity of 5 cm per minute from the top of the head to the ankles of the subject. The contribution to the 1311 photopeak from 40K existing in the subject was corrected. 1311 in excreta was followed up with the same whole-body counter by measur ing the sample in a 2 liter-vinylchloride container of 20 cm diameter which was inserted between the 2 Na.I detectors. The amount of 1311 was determined in use of some standard sources of potassium, 1311 and water alone in the way similar to that for thyroidal 1311 measurement. In the measurements of the whole-body and the excreta, the two detectors were used.
Urine samples were collected at time intervals of 0 to 3, 3 to 6, 6 to 12 and 12 to 24 hours in the first 24 hours postdose. Afterwards full volume of urine for 24 hours preceding 1311 thyroidal retention measurement, was collected. A 24-hr feces was also collected each day for 3 days after administration.
RESULTS AND DISCUSSIONS
1311 thyroidal uptake is presented in Fig . 1 in relation to time after dose.
The uptake attained peak values of 28.9 and 10.3% of the initial dose 24 hours after the administration for subjects A and B, respectively. Afterwards 1311 in the thyroid was eliminated exponentially with effective half-times of 6.7 and 6.2 days, respectively. Including the period before the attainment of peak, the reten tion in the thyroid was best fitted with a 2-term exponential function under the conditions that it passed through the maximal point of uptake. The equations for subjects A and B were as follows: R (t) = 33.9 exp ( 0.693/6.4 t) 24.4 exp ( 0.693/0.25 t) for subject A, R (t) = 11.6 exp ( 0.693/6.1 t) -1 .9 exp ( 0.693/0.42 t) for subject B where R (t) is the retention at the t-th day postdose in terms of percent of the initial dose. These equations suggest existence of at least 2 different compartments for 131I metabolism in the subjects . The longer half-times in these equations coincided with those observed for thyroid after the maximal uptake attained . This suggests that the compartment for the first term should be the thyroid . This means, in tern, that the metabolism of 131I in the thyroid after the maximal peak attained is slightly modified with 131I in the other compartment with much shorter effective half-time. The second term explains approximately the retention until the maximal up take attainment in the thyroid.
131I in the thighs attained a maximal level 3 hours after dose . Thereafter, it decreased quickly with a half-time of 0.2 to 0.3 day. A small peak was observed at the second day for subject B but it was tentative. After the 4th day postdose, the activity was substantially decreased under a detection limit. The retentions were fitted 2-term exponential functions as follows: The rate constants in the first term of these formulas have the same order as those in the second term in the retention function for the thyroid which was assumed for 131I in blood vessel. The second term with a half-time of less than 10 minutes for subject B may be contamination via excreted urine.
1311 was excreted exponentially in urine with a rather high speed as indicated in Fig. 3 . Rates of 1311 elimination via urine in terms of percent of the initially given dose per hour were expressed as follows:
U (t) = 9.63 exp ( 0.693/0.22 t) for subject A, and U (t) = 8.20 exp ( 0.693/0.29 t) for subject B.
The amount excreted per hour reduces approximately 1/2 at day 3 at a rate of about 0.21 to 0.30 day-', or 5 to 7.2 hour-1 for subjects A and B, respectively. The elimination rates have the order similar to those in the second terms of reten tion functions for the thyroid, the neck and the whole-body and the first term for the thighs. A compartment related to these parts of body and urine in common is blood vessel. Radioiodine injected as an inorganic form is transferred very rapidly from blood to urine'' 8). As indicated in Fig. 4 , '"1 in this study is mainly excreted into urine through renal filtration of blood after circulating through the parts other than the thyroid. The elimination rate, thus, may be basically similar to that from blood vessel. The values obtained in the periods, 0 3, 3 6, 6 12 and 12 24 hours after 1311 administration, were divided by the time to obtain the average rates of 131, urinary excretion. The rates are plotted against the midpoints of time for the sample collection.
Open and solid circles are for subjects A and B, respectively. The elimination rate in the second term is almost similar to that in the thighs. During the period of 3 days postdose, the amounts of 1311 excreted in 24-hr urine in terms of percent of the initial dose were represented by the following equations; Um (t) = 649 exp ( 0.693/0.29 t) for subject A, and U (m) = 1019 exp ( 0.693/0.28 t) for subject B.
Afterwards the rates were about 0.2 to 0.3 in terms of the initially given dose respectively for subjects A and B although the fluctuation was considerably large with the coefficient of variation of 70%.
A small part of ingested 1311 was excreted into feces. It amounted less than 1 and 2% for subjects A and B, respectively.
The cumulated amount of 1311 excreted in urine is given in Fig. 5 . 1311 in excreta was found in the first 24-hr urine as much as 72 and 88% of initially given dose respectively for subjects A and B. In other words, about 99% of 1311 elimi nated in excreta within 20 days postdose was found in urine excreted into the first 4 days.
It has been pointed out that 131I intake can be estimated roughly by a sum of the thyroid uptake rate at 24 hours postdose and the amount found in urine within the first 24 hours9). In the case of intake as a form of inorganic iodide, it was substantiated in this study, either. 
Both effective
and biological half-times for Japanese are summarized in Table   1 . The half-times are fairly shorter than those in the reference man by ICRP2).
With theoretical considerations using a four-compartment model developed by
Brownell and from experimental data on human subjects whose stable iodine in take ranged from 50 to 300 µg a day, Colard et al. indicated that the biological half-time was approximately related to daily intake of stable iodine in power functions). In the present study an amount of stable iodine excreted in daily urine was determined spectrometrically in some samples in place of measuring the intake of stable iodine. The amounts before 1311 administration were as follows: 0.29 mg at day 15 for subject A and 2.0 and 5.4 mg at respectively days 12 and 6 for subject B. The difference in the amount of stable iodine excreted into daily urine is large between 2 subjects. Assuming that iodine in food are metabolized in the way similar to that in the form of Na.I in aquatic solution, stable iodine as much as over 70% of that taken into gastrointestinal tract will be found in urine excreted within 24 hours after intake.
Larger amount of stable iodine intake, thus, is estimated for subject B than for subject A, which does not contradict with their statement about the amount of stable iodine intake as explained before. It is understandable that this differ ence had a direct effect on the difference of metabolism of 131I like the uptake by the thyroid and the half-time in the thyroid.
The amount of stable iodine intake by subject B, however, is still in an ex tremely high level for that by Caucasians). This means that the Japanese take appreciable amount of stable iodine unconciously from foodstuffs like seasoning.
The substantially limited distribution of 131I in the thyroid alone implies the importance of dose calculation to this small organ. The maximal concentration is attained in the different periods postdose for various radioactive iodines de pending on their physical half-times. The situation is similar to the effective half time. 1291, mainly produced by nuclear fission reaction is a soft-/3 emitter with a very long physical half-time. Therefore,. the effective half-time in the thyroid equals the biological half-time. The maximal thyroid uptake attains a little later than that for 131I dependent on the difference of their physical half-times. After making correction for the physical decay, the best fit to the retention in the thyroid was as follows in this study: R (t) = 32.2 exp ( 0.693/38.5 t) 25.7 exp ( 0.693/0.14 t) for subject A, and R (t) = 10.9 exp ( 0.693/28.9 t) -1 .2 exp ( 0.693/0.52 t) for subject B.
The maximal uptake of 32.8 and 11.2% of the initial dose appeared 48.8 and 24.8 hours after administration for subjects A and B, respectively. Based on the present metabolic data, the dose commitment due to 131I intake by these subjects was estimated by the MIRD method 11-16). The dose commit ments to the total body and the thyroid were estimated separately. The whole body retention in terms of percent dose of the ingested 1311 was estimated from the count rates at each measuring time assuming that the'counting efficiency was not affected by the different distribution of 131I in the subject with lapse of time after dose. Since the differences in the mass of total body and thyroid contribute the absorbed fraction in tissues for penetrating radiations, some corrections for the absorbed fractions by MIRD due to the smaller physique of the present subjects, 67 and 62 kg in body weight for respectively subjects A and B, were made for both total body and thyroid") as target organs from these parts of body as source organs, and vice versa.
The dose commitments were estimated to be 1.19 and 0.39 mGy (119 and 39 mrads) to the thyroid and 1 and 0.5 pGy (0.1 and 0.05 mrad) to the total body for subjects A and B, respectively.
The dose calculation using the "S", values by MIRD16) gave almost the same results. This elicits that at least in the adult males the retention pattern and the attained fraction in the target organ are the most important in the dose calcula tion.
ICRP recommended 120 days of biological half-time for iodine retention in the thyroid'). Much shorter half-times, about 30 to 40 days, were, however, found for Japanese in the present study and this rather shorter half-time would be characteristic to Japanese as indicated in Table 1 . While, the maximal thyroid uptakes of the present subjects did not exceed the value given by ICRP2) and were within the distribution of thyroidal uptake for iodine by normal Japanese').
Metabolic studies should be continued not to overestimte the internal radia tion dose from radioactive iodines by applying the values of biological parameters by ICRP without sufficient consideration on physiological implications of iodine in dietary customs for Japanese.
